Combination of bis (α‐furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through down‐regulating inflammatory pathways in high‐fat diet‐induced obese C57BL/6J mice

The effects of the combination of bis (α‐furancarboxylato) oxovanadium (IV) (BFOV) and metformin (Met) on hepatic steatosis were investigated in high‐fat diet‐induced obese C57BL/6J mice (HFC57 mice) for 6 weeks. Oral glucose tolerance test was performed to evaluate glucose metabolism. Moreover, blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Quan, Li, Linyi, Gao, Lihui, Li, Caina, Huan, Yi, Lei, Lei, Cao, Hui, Li, Ling, Gao, Anli, Liu, Shuainan, Shen, Zhufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251758/
https://www.ncbi.nlm.nih.gov/pubmed/33599105
http://dx.doi.org/10.1111/bcpt.13573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251758/
https://www.ncbi.nlm.nih.gov/pubmed/33599105
http://dx.doi.org/10.1111/bcpt.13573

Ejemplares similares